Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000814711 | SCV000955132 | likely benign | Noonan syndrome 9 | 2023-05-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003166336 | SCV003911939 | uncertain significance | Cardiovascular phenotype | 2022-11-04 | criteria provided, single submitter | clinical testing | The p.E990G variant (also known as c.2969A>G), located in coding exon 19 of the SOS2 gene, results from an A to G substitution at nucleotide position 2969. The glutamic acid at codon 990 is replaced by glycine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |